{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:42:23Z","timestamp":1771562543392,"version":"3.50.1"},"publisher-location":"Cham","reference-count":163,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030663056","type":"print"},{"value":"9783030663063","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_339","type":"book-chapter","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T09:02:58Z","timestamp":1575882178000},"page":"107-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Use of Botulinum Toxin for Treatment of the Dystonias"],"prefix":"10.1007","author":[{"given":"Alfredo","family":"Berardelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"issue":"1","key":"339_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000204903","volume":"45","author":"A Agrawal","year":"2009","unstructured":"Agrawal A, Cincu R, Joharapurkar SR, Bhake A, Hiwale KM (2009) Hemorrhage in brainstem cavernoma presenting with torticollis. Pediatr Neurosurg 45(1):49\u201352","journal-title":"Pediatr Neurosurg"},{"issue":"4","key":"339_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","volume":"591","author":"N Akaike","year":"2013","unstructured":"Akaike N, Shin MC, Wakita M, Torii Y, Harakawa T, Ginnaga A, Kato K, Kaji R, Kozaki S (2013) Transsynaptic inhibition of spinal transmission by A2 botulinum toxin. J Physiol 591(4):1031\u20131043","journal-title":"J Physiol"},{"key":"339_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bathia K, Bressman SB et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863\u2013873","journal-title":"Mov Disord"},{"issue":"1","key":"339_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.wnf.0000152044.43822.42","volume":"28","author":"N Allam","year":"2005","unstructured":"Allam N, Fonte-Boa PM, Tomaz CA, Brasil-Neto JP (2005) Lack of effect of botulinum toxin on cortical excitability in patients with cranial dystonia. Clin Neuropharmacol 28(1):1\u20135","journal-title":"Clin Neuropharmacol"},{"key":"339_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2016.06.011","volume":"31","author":"E Antelmi","year":"2016","unstructured":"Antelmi E, Di Stasio F, Rocchi L et al (2016) Impaired eye blink classical conditioning distinguishes dystonic patients with and without tremor. Parkinsonism Relat Disord 31:23\u201327","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"339_CR6","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","volume":"28","author":"F Antonucci","year":"2008","unstructured":"Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M (2008) Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 28(14):3689\u20133696","journal-title":"J Neurosci"},{"issue":"Pt A","key":"339_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.toxicon.2015.06.003","volume":"107","author":"MZ Atassi","year":"2015","unstructured":"Atassi MZ (2015) Molecular basis of immunogenicity to botulinum neurotoxins and uses of the defined antigenic regions. Toxicon 107(Pt A):50\u201358","journal-title":"Toxicon"},{"key":"339_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.clinph.2017.08.020","volume":"129","author":"L Avanzino","year":"2018","unstructured":"Avanzino L, Ravaschio A, Lagravinese G, Bonassi G, Abbruzzese G, Pelosin E (2018) Adaptation of feedforward movement control is abnormal in patients with cervical dystonia and tremor. Clin Neurophysiol 129:319\u2013326","journal-title":"Clin Neurophysiol"},{"key":"339_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.parkreldis.2018.04.030","volume":"54","author":"M Avenali","year":"2018","unstructured":"Avenali M, De Icco R, Tinazzi M, Defazio G, Tronconi L, Sandrini G, Tassorelli C (2018) Pain in focal dystonias \u2013 a focused review to address an important component of the disease. Parkinsonism Relat Disord 54:17\u201324","journal-title":"Parkinsonism Relat Disord"},{"key":"339_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-018-0023-6","volume":"4","author":"B Balint","year":"2018","unstructured":"Balint B, Mencacci NE, Valente EM et al (2018) Dystonia. Nat Rev Dis Primers 4:25","journal-title":"Nat Rev Dis Primers"},{"key":"339_CR11","doi-asserted-by":"publisher","first-page":"10363","DOI":"10.1523\/JNEUROSCI.3564-08.2008","volume":"28","author":"S Beck","year":"2008","unstructured":"Beck S, Richardson SP, Shamim EA, Dang N, Schubert M, Hallett M (2008) Short intracortical and surround inhibition are selectively reduced during movement initiation in focal hand dystonia. J Neurosci 28:10363\u201310369","journal-title":"J Neurosci"},{"issue":"3","key":"339_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s12640-009-9023-3","volume":"15","author":"AR Bentivoglio","year":"2009","unstructured":"Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo Fermo S, Albanese A (2009) Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs. Neurotox Res 15(3):224\u2013231","journal-title":"Neurotox Res"},{"issue":"2","key":"339_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12640-017-9737-6","volume":"32","author":"AR Bentivoglio","year":"2017","unstructured":"Bentivoglio AR, Di Stasio E, Mulas D, Cerbarano ML, Ialongo T, Laurienzo A, Petracca M (2017) Long-term abobotulinumtoxin A treatment of cervical dystonia. Neurotox Res 32(2):291\u2013300","journal-title":"Neurotox Res"},{"key":"339_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/brain\/108.3.593","volume":"108","author":"A Berardelli","year":"1985","unstructured":"Berardelli A, Rothwell JC, Day BL, Marsden CD (1985) Pathophysiology of blepharospasm and oromandibular dystonia. Brain 108:593\u2013608","journal-title":"Brain"},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/brain\/121.7.1195","volume":"121","author":"A Berardelli","year":"1998","unstructured":"Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD (1998) The pathophysiology of primary dystonia. Brain 121:1195\u20131212","journal-title":"Brain"},{"issue":"1-2","key":"339_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.psychres.2015.07.076","volume":"229","author":"I Berardelli","year":"2015","unstructured":"Berardelli I, Ferrazzano G, Pasquini M, Biondi M, Berardelli A, Fabbrini G (2015) Clinical course of psychiatric disorders in patients with cervical dystonia. Psychiatry Res 229(1-2):583\u2013585","journal-title":"Psychiatry Res"},{"issue":"1","key":"339_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14737175.2019.1555475","volume":"19","author":"I Berardelli","year":"2019","unstructured":"Berardelli I, Pasquini M, Conte A, Bologna M, Berardelli A, Fabbrini G (2019) Treatment of psychiatric disturbances in common hyperkinetic movement disorders. Expert Rev Neurother 19(1):55\u201365","journal-title":"Expert Rev Neurother"},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/jnnp-2016-315461","volume":"88","author":"BD Berman","year":"2017","unstructured":"Berman BD, Junker J, Shelton E et al (2017) Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry 88:595\u2013602","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"339_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/000348940010900215","volume":"109","author":"S Bielamowicz","year":"2000","unstructured":"Bielamowicz S, Ludlow CL (2000) Effects of botulinum toxin on pathophysiology in spasmodic dysphonia. Ann Otol Rhinol Laryngol 109(2):194\u2013203","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"339_CR20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/01.wnr.0000230500.03330.01","volume":"17","author":"AJ Blood","year":"2006","unstructured":"Blood AJ, Tuch DS, Makris N, Makhlouf ML, Sudarsky LR, Sharma N (2006) White matter abnormalities in dystonia normalize after botulinum toxin treatment. Neuroreport 17:1251\u20131255","journal-title":"Neuroreport"},{"key":"339_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fneur.2019.00265","volume":"10","author":"AJ Blood","year":"2019","unstructured":"Blood AJ, Kuster JK, Waugh JL, Levenstein JM, Multhaupt-Buell TJ, Sudarsky LR, Breiter HC, Sharma N (2019) White matter changes in cervical dystonia relate to clinical effectiveness of botulinum toxin treatment. Front Neurol 10:265","journal-title":"Front Neurol"},{"issue":"3","key":"339_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000116936","volume":"33","author":"D Boghen","year":"1993","unstructured":"Boghen D, Flanders M (1993) Effectiveness of botulinum toxin in the treatment of spasmodic torticollis. Eur Neurol 33(3):199\u2013203","journal-title":"Eur Neurol"},{"issue":"2","key":"339_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00006534-199102000-00010","volume":"87","author":"GE Borodic","year":"1991","unstructured":"Borodic GE, Mills L, Joseph M (1991) Botulinum A toxin for the treatment of adult-onset spasmodic torticollis. Plast Reconstr Surg 87(2):285\u2013289","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"339_CR24","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/01.WNL.0000095965.36574.0F","volume":"61","author":"B Boroojerdi","year":"2003","unstructured":"Boroojerdi B, Cohen LG, Hallett M (2003) Effects of botulinum toxin on motor system excitability in patients with writer\u2019s cramp. Neurology 61(11):1546\u20131550","journal-title":"Neurology"},{"issue":"7","key":"339_CR25","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","volume":"53","author":"A Brashear","year":"1999","unstructured":"Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53(7):1439\u20131446","journal-title":"Neurology"},{"key":"339_CR26","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","volume":"6","author":"MF Brin","year":"1997","unstructured":"Brin MF (1997) Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 6:S146\u2013S168","journal-title":"Muscle Nerve Suppl"},{"issue":"7","key":"339_CR27","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","volume":"53","author":"MF Brin","year":"1999","unstructured":"Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O\u2019Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53(7):1431\u20131438","journal-title":"Neurology"},{"issue":"10","key":"339_CR28","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/mds.22157","volume":"23","author":"MF Brin","year":"2008","unstructured":"Brin MF, Comella CL, Jankovic J, Lai F, Naumann M, CD-017 BoNTA Study Group (2008) Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord 23(10):1353\u20131360","journal-title":"Mov Disord"},{"key":"339_CR29","doi-asserted-by":"publisher","first-page":"101792","DOI":"10.1016\/j.nicl.2019.101792","volume":"22","author":"S Brodoehl","year":"2019","unstructured":"Brodoehl S, Wagner F, Prell T, Klingner C, Witte OW, G\u00fcnther A (2019) Cause or effect: altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment. Neuroimage Clin 22:101792","journal-title":"Neuroimage Clin"},{"issue":"Pt 5","key":"339_CR30","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/brain\/121.5.977","volume":"121","author":"ML Byrnes","year":"1998","unstructured":"Byrnes ML, Thickbroom GW, Wilson SA, Sacco P, Shipman JM, Stell R, Mastaglia FL (1998) The corticomotor representation of upper limb muscles in writer\u2019s cramp and changes following botulinum toxin injection. Brain 121(Pt 5):977\u2013988","journal-title":"Brain"},{"key":"339_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.toxicon.2017.10.027","volume":"147","author":"M Caleo","year":"2018","unstructured":"Caleo M, Restani L (2018) Direct central nervous system effects of botulinum neurotoxin. Toxicon 147:68\u201372","journal-title":"Toxicon"},{"issue":"5","key":"339_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1590\/S0004-282X2011000600004","volume":"69","author":"CH Camargo","year":"2011","unstructured":"Camargo CH, Teive HA, Becker N, Munhoz RP, Werneck LC (2011) Botulinum toxin type A and cervical dystonia: a seven-year follow-up. Arq Neuropsiquiatr 69(5):745\u2013750","journal-title":"Arq Neuropsiquiatr"},{"issue":"6","key":"339_CR33","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/toxins7062321","volume":"7","author":"CH Camargo","year":"2015","unstructured":"Camargo CH, Cattai L, Teive HA (2015) Pain relief in cervical dystonia with botulinum toxin treatment. Toxins (Basel) 7(6):2321\u20132335","journal-title":"Toxins (Basel)"},{"issue":"6","key":"339_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1046\/j.1468-1331.2000.00143.x","volume":"7","author":"P Ce","year":"2000","unstructured":"Ce P (2000) Central effects of botulinum toxin: study of brainstem auditory evoked potentials. Eur J Neurol 7(6):747","journal-title":"Eur J Neurol"},{"key":"339_CR35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00415-014-7343-6","volume":"261","author":"PD Charles","year":"2014","unstructured":"Charles PD, Adler CH, Stacy M, Comella C, Jankovic J, Manack Adams A, Schwartz M, Brin MF (2014) Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy). J Neurol 261:1309\u20131319","journal-title":"J Neurol"},{"key":"339_CR36","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1212\/WNL.51.5.1494","volume":"51","author":"R Chen","year":"1998","unstructured":"Chen R, Karp BI, Hallett M (1998) Botulinum toxin type F for treatment of dystonia: long-term experience. Neurology 51:1494\u20131496","journal-title":"Neurology"},{"issue":"4","key":"339_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/mds.870100411","volume":"10","author":"R Cole","year":"1995","unstructured":"Cole R, Hallett M, Cohen LG (1995) Double-blind trial of botulinum toxin for treatment of focal hand dystonia. Mov Disord 10(4):466\u2013471","journal-title":"Mov Disord"},{"key":"339_CR38","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/jnnp.2004.056614","volume":"76","author":"C Colosimo","year":"2005","unstructured":"Colosimo C, Pantano P, Calistri V, Totaro P, Fabbrini G, Berardelli A (2005) Diffusion tensor imaging in primary cervical dystonia. J Neurol Neurosurg Psychiatry 76:1591\u20131593","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"339_CR39","doi-asserted-by":"publisher","unstructured":"Colosimo C, Charles D, Misra VP, Maisonobe P, Om S, INTEREST IN CD2 Study Group (2019) How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study. J Neurol. https:\/\/doi.org\/10.1007\/s00415-019-09527-2","DOI":"10.1007\/s00415-019-09527-2"},{"key":"339_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.toxicon.2018.02.006","volume":"147","author":"CL Comella","year":"2018","unstructured":"Comella CL (2018) Systematic review of botulinum toxin treatment for oromandibular dystonia. Toxicon 147:96\u201399","journal-title":"Toxicon"},{"issue":"9","key":"339_CR41","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","volume":"65","author":"CL Comella","year":"2005","unstructured":"Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S, Fan W, Dystonia Study Group (2005) Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 65(9):1423\u20131429","journal-title":"Neurology"},{"key":"339_CR42","doi-asserted-by":"crossref","unstructured":"Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S, U.S. XEOMIN Cervical Dystonia Study Group (2011) Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN\u00ae, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci 308(1\u20132):103-109","DOI":"10.1016\/j.jns.2011.05.041"},{"issue":"10","key":"339_CR43","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.clinph.2007.07.004","volume":"118","author":"MF Contarino","year":"2007","unstructured":"Contarino MF, Kruisdijk JJ, Koster L, Ongerboer de Visser BW, Speelman JD, Koelman JH (2007) Sensory integration in writer\u2019s cramp: comparison with controls and evaluation of botulinum toxin effect. Clin Neurophysiol 118(10):2195\u20132206","journal-title":"Clin Neurophysiol"},{"key":"339_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fneur.2017.00035","volume":"8","author":"MF Contarino","year":"2017","unstructured":"Contarino MF, Van Den Dool J, Balash Y, Bhatia K, Giladi N, Koelman JH, Lokkegaard A, Marti MJ, Postma M, Relja M, Skorvanek M, Speelman JD, Zoons E, Ferreira JJ, Vidailhet M, Abanese A, Tijssen MA (2017) Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin. Front Neurol 8:35","journal-title":"Front Neurol"},{"key":"339_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1468-1331.2009.02840.x","volume":"17","author":"A Conte","year":"2010","unstructured":"Conte A, Fabbrini G, Belvisi D, Marsili L, Di Stasio F, Berardelli A (2010) Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm. Eur J Neurol 17:449\u2013455","journal-title":"Eur J Neurol"},{"key":"339_CR46","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/j.parkreldis.2015.09.001","volume":"22","author":"A Conte","year":"2016","unstructured":"Conte A, Berardelli I, Ferrazzano G, Pasquini M, Berardelli A, Fabbrini G (2016) Non-motor symptoms in patients with adult-onset focal dystonia: sensory and psychiatric disturbances. Parkinsonism Relat Disord 22:S111\u2013S114","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"339_CR47","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1002\/mds.27530","volume":"33","author":"A Conte","year":"2018","unstructured":"Conte A, Belvisi D, De Bartolo MI, Manzo N, Cortese FN, Tartaglia M, Ferrazzano G, Fabbrini G, Berardelli A (2018) Abnormal sensory gating in patients with different types of focal dystonias. Mov Disord 33(12):1910\u20131917","journal-title":"Mov Disord"},{"key":"339_CR48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41582-019-0137-9","volume":"15","author":"A Conte","year":"2019","unstructured":"Conte A, Defazio G, Hallett M, Fabbrini G, Berardelli A (2019) The role of sensory information in the pathophysiology of focal dystonias. Nat Rev Neurol 15:224\u2013233","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"339_CR49","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/brain\/awz112","volume":"142","author":"DT Corp","year":"2019","unstructured":"Corp DT, Joutsa J, Darby RR, Delnooz CCS, van de Warrenburg BPC, Cooke D, Prudente CN, Ren J, Reich MM, Batla A, Bhatia KP, Jinnah HA, Liu H, Fox MD (2019) Network localization of cervical dystonia based on causal brain lesions. Brain 142(6):1660\u20131674","journal-title":"Brain"},{"issue":"12","key":"339_CR50","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1212\/01.wnl.0000345010.98495.fc","volume":"72","author":"A Curr\u00e0","year":"2009","unstructured":"Curr\u00e0 A, Berardelli A (2009) Do the unintended actions of botulinum toxin at distant sites have clinical implications? Neurology 72(12):1095\u20131099","journal-title":"Neurology"},{"key":"339_CR51","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1212\/WNL.0000000000001341","volume":"84","author":"G Defazio","year":"2015","unstructured":"Defazio G, Conte A, Gigante AF, Fabbrini G, Berardelli A (2015) Is tremor in dystonia a phenotypic feature of dystonia? Neurology 84:1053\u20131059","journal-title":"Neurology"},{"key":"339_CR52","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/mds.26934","volume":"32","author":"G Defazio","year":"2017","unstructured":"Defazio G, Hallett M, Jinnah HA, Conte A, Berardelli A (2017) Blepharospasm 40 years later. Mov Disord 32:498\u2013509","journal-title":"Mov Disord"},{"key":"339_CR53","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/mds.25029","volume":"27","author":"CCS Delnooz","year":"2012","unstructured":"Delnooz CCS, Helmich RC, Toni I, van de Warrenburg BPC (2012) Reduced parietal connectivity with a premotor writing area in writer\u2019s cramp. Mov Disord 27:1425\u20131431","journal-title":"Mov Disord"},{"key":"339_CR54","doi-asserted-by":"publisher","first-page":"e62877","DOI":"10.1371\/journal.pone.0062877","volume":"8","author":"CCS Delnooz","year":"2013","unstructured":"Delnooz CCS, Pasman JW, Beckmann CF, van de Warrenburg BPC (2013) Task-free functional MRI in cervical dystonia reveals multi-network changes that partially normalize with botulinum toxin. PLoS One 8:e62877","journal-title":"PLoS One"},{"key":"339_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00429-013-0671-y","volume":"220","author":"CCS Delnooz","year":"2015","unstructured":"Delnooz CCS, Pasman JW, Beckmann CF, van de Warrenburg BPC (2015a) Altered striatal and pallidal connectivity in cervical dystonia. Brain Struct Funct 220:513\u2013523","journal-title":"Brain Struct Funct"},{"key":"339_CR56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nbd.2014.10.013","volume":"73","author":"CCS Delnooz","year":"2015","unstructured":"Delnooz CCS, Pasman JW, van de Warrenburg BPC (2015b) Dynamic cortical gray matter volume changes after botulinum toxin in cervical dystonia. Neurobiol Dis 73:327\u2013333","journal-title":"Neurobiol Dis"},{"key":"339_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/brain\/awh665","volume":"129","author":"C Dresel","year":"2006","unstructured":"Dresel C, Haslinger B, Castrop F, Wohlschlaeger AM, Ceballos-Baumann AO (2006) Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia. Brain 129:36\u201346","journal-title":"Brain"},{"key":"339_CR58","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/mds.23497","volume":"26","author":"C Dresel","year":"2011","unstructured":"Dresel C, Bayer F, Castrop F, Rimpau C, Zimmer C, Haslinger B (2011) Botulinum toxin modulates basal ganglia but not deficient somatosensory activation in orofacial dystonia. Mov Disord 26:1496\u20131502","journal-title":"Mov Disord"},{"key":"339_CR59","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1136\/jnnp-2013-307127","volume":"85","author":"C Dresel","year":"2014","unstructured":"Dresel C, Li Y, Wilzeck V, Castrop F, Zimmer C, Haslinger B (2014) Multiple changes of functional connectivity between sensorimotor areas in focal hand dystonia. J Neurol Neurosurg Psychiatry 85:1245\u20131252","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"339_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0304-3940(98)00775-7","volume":"256","author":"R Eleopra","year":"1998","unstructured":"Eleopra R, Tugnoli V, Rossetto O, De Grandis D, Montecucco C (1998) Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett 256:135\u2013138","journal-title":"Neurosci Lett"},{"key":"339_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF03033930","volume":"9","author":"R Eleopra","year":"2006","unstructured":"Eleopra R, Tugnoli V, Quatrale R, Rossetto O, Montecucco C, Dressler D (2006) Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F. Neurotox Res 9:127\u2013131","journal-title":"Neurotox Res"},{"key":"339_CR62","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.clinph.2012.11.004","volume":"124","author":"R Eleopra","year":"2013","unstructured":"Eleopra R, Montecucco C, Devigili G, Lettieri C, Rinaldo S, Verriello L, Pirazzini M, Caccin P, Rossetto O (2013) Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study. Clin Neurophysiol 124:999\u20131004","journal-title":"Clin Neurophysiol"},{"key":"339_CR63","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/S1388-2457(99)00127-3","volume":"110","author":"J Erdal","year":"1999","unstructured":"Erdal J, Ostergaard L, Fuglsang-Frederiksen A, Werdelin L, Dalager T, Sj\u00f6 O, Regeur L (1999) Long-term botulinum toxin treatment of cervical dystonia \u2013 EMG changes in injected and noninjected muscles. Clin Neurophysiol 110:1650\u20131654","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"339_CR64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12640-015-9565-5","volume":"29","author":"M Fabbri","year":"2016","unstructured":"Fabbri M, Leodori G, Fernandes RM, Bhidayasiri R, Marti MJ, Colosimo C, Ferreira JJ (2016) Neutralizing antibody and botulinum toxin therapy: a systematic review and meta-analysis. Neurotox Res 29(1):105\u2013117","journal-title":"Neurotox Res"},{"key":"339_CR65","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mds.22983","volume":"25","author":"G Fabbrini","year":"2010","unstructured":"Fabbrini G, Berardelli I, Moretti G et al (2010) Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord 25:459\u2013465","journal-title":"Mov Disord"},{"key":"339_CR66","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/mds.23615","volume":"26","author":"G Fabbrini","year":"2011","unstructured":"Fabbrini G, Berardelli I, Moretti G, Pasquini M, Colosimo C, Berardelli A (2011) Nonmotor symptoms in adult-onset focal dystonia: psychiatric abnormalities. Mov Disord 26:1765\u20131766","journal-title":"Mov Disord"},{"key":"339_CR67","doi-asserted-by":"publisher","unstructured":"Ferrazzano G, Berardelli I, Conte A, Baione V, Concolato C, Belvisi D, Fabbrini G, Defazio G, Berardelli A (2019) Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications. J Neurol. https:\/\/doi.org\/10.1007\/s00415-019-09484-w","DOI":"10.1007\/s00415-019-09484-w"},{"issue":"2","key":"339_CR68","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.parkreldis.2014.09.034","volume":"21","author":"JJ Ferreira","year":"2015","unstructured":"Ferreira JJ, Colosimo C, Bhidayasiri R, Marti MJ, Maisonobe P, Om S (2015) Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia. Parkinsonism Relat Disord 21(2):111\u2013115","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"339_CR69","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1017\/S0317167100038506","volume":"23","author":"C Geenen","year":"1996","unstructured":"Geenen C, Consky E, Ashby P (1996) Localizing muscles for botulinum toxin treatment of focal hand dystonia. Can J Neurol Sci 23(3):194\u2013197","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"339_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/1531-8249(200007)48:1<20::AID-ANA5>3.0.CO;2-U","volume":"48","author":"F Gilio","year":"2000","unstructured":"Gilio F, Curr\u00e0 A, Lorenzano C, Modugno N, Manfredi M, Berardelli A (2000) Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol 48(1):20\u201326","journal-title":"Ann Neurol"},{"issue":"5","key":"339_CR71","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1017\/S0317167100010817","volume":"37","author":"HS Gill","year":"2010","unstructured":"Gill HS, Kraft SP (2010) Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm. Can J Neurol Sci 37(5):631\u2013636","journal-title":"Can J Neurol Sci"},{"issue":"9","key":"339_CR72","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/jnnp.55.9.844","volume":"55","author":"P Girlanda","year":"1992","unstructured":"Girlanda P, Vita G, Nicolosi C, Milone S, Messina C (1992) Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 55(9):844\u2013845","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"339_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mds.870110107","volume":"11","author":"P Girlanda","year":"1996","unstructured":"Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Messina C (1996) Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord 11(1):27\u201331","journal-title":"Mov Disord"},{"key":"339_CR74","first-page":"307","volume":"21","author":"F Grandas","year":"1998","unstructured":"Grandas F, Traba A, Alonso F, Esteban A (1998) Blink reflex recovery cycle in patients with blepharospasm unilaterally treated with botulinum toxin. Clin Neuropharmacol 21:307\u2013311","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"339_CR75","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0041-0101(78)90189-7","volume":"16","author":"E Habermann","year":"1978","unstructured":"Habermann E, Erdmann G (1978) Pharmacokinetic and histoautoradiographic evidence for the intraaxonal movement of toxin in the pathogenesis of tetanus. Toxicon 16(6):611\u2013623","journal-title":"Toxicon"},{"key":"339_CR76","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2010.08.025","volume":"42","author":"M Hallett","year":"2011","unstructured":"Hallett M (2011) Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis 42:177\u2013184","journal-title":"Neurobiol Dis"},{"key":"339_CR77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.toxicon.2015.07.013","volume":"107","author":"M Hallett","year":"2015","unstructured":"Hallett M (2015) Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. Toxicon 107:64\u201367","journal-title":"Toxicon"},{"key":"339_CR78","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","volume":"67","author":"M Hallett","year":"2013","unstructured":"Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J (2013) Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon 67:94\u2013114","journal-title":"Toxicon"},{"key":"339_CR79","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/mds.26893","volume":"32","author":"B Haslinger","year":"2017","unstructured":"Haslinger B, No\u00e9 J, Altenm\u00fcller E, Riedl V, Zimmer C, Mantel T, Dresel C (2017) Changes in resting-state connectivity in musicians with embouchure dystonia. Mov Disord 32:450\u2013458","journal-title":"Mov Disord"},{"key":"339_CR80","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/01.WNL.0000137113.39225.FA","volume":"63","author":"GA Heiman","year":"2004","unstructured":"Heiman GA, Ottman R, Saunders-Pullman RJ, Ozelius LJ, Risch NJ, Bressman SB (2004) Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology 63:631\u2013637","journal-title":"Neurology"},{"issue":"6","key":"339_CR81","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/mds.10252","volume":"17","author":"GY Hsiung","year":"2002","unstructured":"Hsiung GY, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O (2002) Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 17(6):1288\u20131293","journal-title":"Mov Disord"},{"key":"339_CR82","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/mds.27229","volume":"33","author":"M Hutchinson","year":"2018","unstructured":"Hutchinson M, McGovern EM, Narasimham S et al (2018) The premotor syndrome of cervical dystonia: disordered processing of salient environmental stimuli. Mov Disord 33:232\u2013237","journal-title":"Mov Disord"},{"key":"339_CR83","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1098\/rstb.2016.0198","volume":"372","author":"M Jahanshahi","year":"2017","unstructured":"Jahanshahi M, Rothwell JC (2017) Inhibitory dysfunction contributes to some of the motor and non-motor symptoms of movement disorders and psychiatric disorders. Philos Trans R Soc Lond B Biol Sci 372:1718","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"9","key":"339_CR84","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","volume":"45","author":"J Jankovic","year":"1995","unstructured":"Jankovic J, Schwartz K (1995) Response and immunoresistance to botulinum toxin injections. Neurology 45(9):1743\u20131746","journal-title":"Neurology"},{"issue":"8","key":"339_CR85","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/mds.23658","volume":"26","author":"J Jankovic","year":"2011","unstructured":"Jankovic J, Comella C, Hanschmann A, Grafe S (2011) Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial. Mov Disord 26(8):1521\u20131528","journal-title":"Mov Disord"},{"issue":"7","key":"339_CR86","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/mds.25567","volume":"28","author":"HA Jinnah","year":"2013","unstructured":"Jinnah HA, Berardelli A, Comella C, Defazio G, Delong MR, Factor S, Galpern WR, Hallett M, Ludlow CL, Perlmutter JS, Rosen AR, Dystonia Coalition Investigators (2013) The focal dystonias: current views and challenges for future research. Mov Disord 28(7):926\u2013943","journal-title":"Mov Disord"},{"key":"339_CR87","doi-asserted-by":"publisher","first-page":"e00894","DOI":"10.1002\/brb3.894","volume":"8","author":"A Jochim","year":"2018","unstructured":"Jochim A, Li Y, Gora-Stahlberg G, Mantel T, Berndt M, Castrop F, Dresel C, Haslinger B (2018) Altered functional connectivity in blepharospasm\/orofacial dystonia. Brain Behav 8:e00894","journal-title":"Brain Behav"},{"issue":"8","key":"339_CR88","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00415-019-09349-2","volume":"266","author":"A Jochim","year":"2019","unstructured":"Jochim A, Meindl T, Mantel T, Zwirner S, Zech M, Castrop F, Haslinger B (2019) Treatment of cervical dystonia with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice. J Neurol 266(8):1879\u20131886","journal-title":"J Neurol"},{"issue":"1","key":"339_CR89","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/mds.870130122","volume":"13","author":"P Kanovsk\u00fd","year":"1998","unstructured":"Kanovsk\u00fd P, Streitov\u00e1 H, Dufek J, Znojil V, Daniel P, Rektor I (1998) Change in lateralization of the P22\/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A. Mov Disord 13(1):108\u2013117","journal-title":"Mov Disord"},{"key":"339_CR90","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jns.2013.05.022","volume":"331","author":"MA Khooshnoodi","year":"2013","unstructured":"Khooshnoodi MA, Factor SA, Jinnah HA (2013) Secondary blepharospasm associated with structural lesions of the brain. J Neurol Sci 331:98\u2013101","journal-title":"J Neurol Sci"},{"key":"339_CR91","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/mds.23681","volume":"26","author":"M Kojovic","year":"2011","unstructured":"Kojovic M, Caronni A, Bologna M, Rothwell JC, Bhatia KP, Edwards MJ (2011) Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Mov Disord 26:1282\u20131289","journal-title":"Mov Disord"},{"key":"339_CR92","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/brain\/awt150","volume":"136","author":"M Kojovic","year":"2013","unstructured":"Kojovic M, Parees I, Kassavetis P et al (2013) Secondary and primary dystonia: pathophysiological differences. Brain 136:2038\u20132049","journal-title":"Brain"},{"issue":"3","key":"339_CR93","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/mds.870120329","volume":"12","author":"JK Krauss","year":"1997","unstructured":"Krauss JK, Seeger W, Jankovic J (1997) Cervical dystonia associated with tumors of the posterior fossa. Mov Disord 12(3):443\u2013447","journal-title":"Mov Disord"},{"issue":"3","key":"339_CR94","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jnnp.2005.083170","volume":"78","author":"JJ Kruisdijk","year":"2007","unstructured":"Kruisdijk JJ, Koelman JH, Ongerboer de Visser BW, de Haan RJ, Speelman JD (2007) Botulinum toxin for writer\u2019s cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry 78(3):264\u2013270","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"339_CR95","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1212\/WNL.55.11.1754","volume":"55","author":"J Kulisevsky","year":"2000","unstructured":"Kulisevsky J, Lle\u00f3 A, Gironell A, Molet J, Pascual-Sedano B, Par\u00e9s P (2000) Bilateral pallidal stimulation for cervical dystonia: dissociated pain and motor improvement. Neurology 55(11):1754\u20131755","journal-title":"Neurology"},{"issue":"6","key":"339_CR96","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.clinph.2019.02.007","volume":"130","author":"A Kutschenko","year":"2019","unstructured":"Kutschenko A, Weisemann J, Kollewe K, Fiedler T, Alvermann S, B\u00f6selt S, Escher C, Garde N, Gingele S, Kaehler SB, Karatschai R, Kr\u00fcger THC, Sikorra S, Tacik P, Wegner F, Wollmann J, Bigalke H, Wohlfarth K, Rummel A (2019) Botulinum neurotoxin serotype D \u2013 a potential treatment alternative for BoNT\/A and B non-responding patients. Clin Neurophysiol 130(6):1066\u20131073","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"339_CR97","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0304-3959(96)03296-4","volume":"69","author":"O Kutvonen","year":"1997","unstructured":"Kutvonen O, Dastidar P, Nurmikko T (1997) Pain in spasmodic torticollis. Pain 69(3):279\u2013286","journal-title":"Pain"},{"key":"339_CR98","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/mus.880100610","volume":"10","author":"DJ Lange","year":"1987","unstructured":"Lange DJ, Brin MF, Warner CL, Fahn S, Lovelace RE (1987) Distant effects of local injection of botulinum toxin. Muscle Nerve 10:552\u2013555","journal-title":"Muscle Nerve"},{"key":"339_CR99","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/mds.10301","volume":"18","author":"MS LeDoux","year":"2003","unstructured":"LeDoux MS, Brady KA (2003) Secondary cervical dystonia associated with structural lesions of the central nervous system. Mov Disord 18:60\u201369","journal-title":"Mov Disord"},{"key":"339_CR100","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1136\/jnnp.2008.170191","volume":"80","author":"R Lencer","year":"2009","unstructured":"Lencer R, Steinlechner S, Stahlberg J et al (2009) Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry 80:1176\u20131179","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"339_CR101","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1212\/WNL.49.3.701","volume":"49","author":"MF Lew","year":"1997","unstructured":"Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, Wallace JD (1997) Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49(3):701\u2013707","journal-title":"Neurology"},{"key":"339_CR102","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s10072-016-2598-6","volume":"37","author":"D Liuzzi","year":"2016","unstructured":"Liuzzi D, Gigante AF, Leo A, Defazio G (2016) The anatomical basis of upper limb dystonia: lesson from secondary cases. Neurol Sci 37:1393\u20131398","journal-title":"Neurol Sci"},{"issue":"3","key":"339_CR103","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/ene.12890","volume":"23","author":"A Macerollo","year":"2016","unstructured":"Macerollo A, Chen JC, Parees I, Sadnicka A, Kassavetis P, Bhatia KP, Kilner JM, Rothwell JC, Edwards MJ (2016) Abnormal movement-related suppression of sensory evoked potentials in upper limb dystonia. Eur J Neurol 23(3):562\u2013568","journal-title":"Eur J Neurol"},{"issue":"4","key":"339_CR104","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1113\/jphysiol.2012.239178","volume":"591","author":"V Marchand-Pauvert","year":"2013","unstructured":"Marchand-Pauvert V, Aymard C, Giboin LS, Dominici F, Rossi A, Mazzocchio R (2013) Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A. J Physiol 591(4):1017\u20131029","journal-title":"J Physiol"},{"key":"339_CR105","doi-asserted-by":"publisher","unstructured":"Marciniec M, Szczepa\u0144ska-Szerej A, Kulczy\u0144ski M, Sapko K, Popek-Marciniec S, Rejdak K (2019) Pain in cervical dystonia and the antinociceptive effects of botulinum toxin: what is currently known? Rev Neurosci. https:\/\/doi.org\/10.1515\/revneuro-2018-0119","DOI":"10.1515\/revneuro-2018-0119"},{"key":"339_CR106","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/brain\/108.2.463","volume":"108","author":"CD Marsden","year":"1985","unstructured":"Marsden CD, Obeso JA, Zarranz JJ, Lang AE (1985) The anatomical basis of symptomatic hemidystonia. Brain 108:463\u2013483","journal-title":"Brain"},{"issue":"11","key":"339_CR107","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/mds.25088","volume":"27","author":"D Martino","year":"2012","unstructured":"Martino D, Berardelli A, Abbruzzese G, Bentivoglio AR, Esposito M, Fabbrini G, Guidubaldi A, Girlanda P, Liguori R, Marinelli L, Morgante F, Santoro L, Defazio G (2012) Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia. Mov Disord 27(11):1447\u20131450","journal-title":"Mov Disord"},{"issue":"5","key":"339_CR109","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.20376","volume":"20","author":"NI Mejia","year":"2005","unstructured":"Mejia NI, Vuong KD, Jankovic J (2005) Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 20(5):592\u2013597","journal-title":"Mov Disord"},{"key":"339_CR110","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.parkreldis.2019.01.023","volume":"63","author":"SO Mittal","year":"2019","unstructured":"Mittal SO, Lenka A, Jankovic J (2019) Botulinum toxin for the treatment of tremor. Parkinsonism Relat Disord 63:31\u201341","journal-title":"Parkinsonism Relat Disord"},{"key":"339_CR111","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/hbm.21250","volume":"33","author":"B Mohammadi","year":"2012","unstructured":"Mohammadi B, Kollewe K, Samii A, Beckmann CF, Dengler R, M\u00fcnte TF (2012) Changes in resting-state brain networks in writer\u2019s cramp. Hum Brain Mapp 33:840\u2013848","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"339_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2958.1994.tb00396.x","volume":"13","author":"C Montecucco","year":"1994","unstructured":"Montecucco C, Schiavo G (1994) Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13(1):1\u20138","journal-title":"Mol Microbiol"},{"issue":"7","key":"339_CR113","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00415-002-0733-1","volume":"249","author":"J M\u00fcller","year":"2002","unstructured":"M\u00fcller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J, Diez J, Homann N, Wenning GK, Schnider P, Poewe W, Austrian Botulinum toxin and Dystonia Study Group (2002) The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 249(7):842\u2013846","journal-title":"J Neurol"},{"issue":"Pt 9","key":"339_CR114","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/brain\/123.9.1813","volume":"123","author":"N Murase","year":"2000","unstructured":"Murase N, Kaji R, Shimazu H, Katayama-Hirota M, Ikeda A, Kohara N, Kimura J, Shibasaki H, Rothwell JC (2000) Abnormal premovement gating of somatosensory input in writer\u2019s cramp. Brain 123(Pt 9):1813\u20131829","journal-title":"Brain"},{"issue":"10","key":"339_CR115","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00221-018-5322-3","volume":"236","author":"M Nevrl\u00fd","year":"2018","unstructured":"Nevrl\u00fd M, Hlu\u0161t\u00edk P, Hok P, Otruba P, T\u00fcd\u00f6s Z, Ka\u0148ovsk\u00fd P (2018) Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study. Exp Brain Res 236(10):2627\u20132637","journal-title":"Exp Brain Res"},{"key":"339_CR116","doi-asserted-by":"crossref","unstructured":"Niemann N, Jankovic J (2018) Botulinum toxin for the treatment of hand tremor. Toxins (Basel) 10(7)","DOI":"10.3390\/toxins10070299"},{"issue":"12","key":"339_CR117","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/mds.26817","volume":"31","author":"SA Norris","year":"2016","unstructured":"Norris SA, Jinnah HA, Espay AJ, Klein C, Br\u00fcggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, Mari Z, Ondo WG, Shih LC, Fox SH, Berardelli A, Testa CM, Cheng FC, Truong D, Nahab FB, Xie T, Hallett M, Rosen AR, Wright LJ, Perlmutter JS (2016) Clinical and demographic characteristics related to onset site and spread of cervical dystonia. Mov Disord 31(12):1874\u20131882","journal-title":"Mov Disord"},{"key":"339_CR118","doi-asserted-by":"publisher","first-page":"596","DOI":"10.5334\/tohm.466","volume":"9","author":"N Novaretti","year":"2019","unstructured":"Novaretti N, Cunha ALN, Bezerra TC, Pena Pereira MA, de Oliveira DS, Macruz Brito MMC, Pimentel AV, Brozinga TR, Foss MP, Tumas V (2019) The prevalence and correlation of non-motor symptoms in adult patients with idiopathic focal or segmental dystonia. Tremor Other Hyperkinet Mov (N Y) 9:596","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"1","key":"339_CR119","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13256-018-1561-y","volume":"12","author":"T Ogawa","year":"2018","unstructured":"Ogawa T, Shojima Y, Kuroki T, Eguchi H, Hattori N, Miwa H (2018) Cervico-shoulder dystonia following lateral medullary infarction: a case report and review of the literature. J Med Case Reports 12(1):34","journal-title":"J Med Case Reports"},{"key":"339_CR120","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jns.2011.03.040","volume":"306","author":"R Opavsk\u00fd","year":"2011","unstructured":"Opavsk\u00fd R, Hlu\u0161t\u00edk P, Otruba P, Ka\u0148ovsk\u00fd P (2011) Sensorimotor network in cervical dystonia and the effect of botulinum toxin treatment: a functional MRI study. J Neurol Sci 306:71\u201375","journal-title":"J Neurol Sci"},{"key":"339_CR121","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/00207454.2011.623807","volume":"122","author":"R Opavsk\u00fd","year":"2012","unstructured":"Opavsk\u00fd R, Hlu\u0161t\u00edk P, Otruba P, Ka\u0148ovsk\u00fd P (2012) Somatosensory cortical activation in cervical dystonia and its modulation with botulinum toxin: an fMRI study. Int J Neurosci 122:45\u201352","journal-title":"Int J Neurosci"},{"issue":"6","key":"339_CR122","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/01.WNF.0000236765.00785.9C","volume":"29","author":"S Papapetropoulos","year":"2006","unstructured":"Papapetropoulos S, Singer C (2006) Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series. Clin Neuropharmacol 29(6):364\u2013367","journal-title":"Clin Neuropharmacol"},{"key":"339_CR123","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fneur.2017.00553","volume":"8","author":"L Paracka","year":"2017","unstructured":"Paracka L, Wegner F, Blahak C, Abdallat M, Saryyeva A, Dressler D, Karst M, Krauss JK (2017) Sensory alterations in patients with isolated idiopathic dystonia: an exploratory quantitative sensory testing analysis. Front Neurol 8:553","journal-title":"Front Neurol"},{"key":"339_CR124","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1474-4422(13)70213-8","volume":"13","author":"N Patel","year":"2014","unstructured":"Patel N, Jankovic J, Hallett M (2014) Sensory aspects of movement disorders. Lancet Neurol 13:100\u2013112","journal-title":"Lancet Neurol"},{"key":"339_CR125","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/jnnp.48.7.650","volume":"48","author":"LC Pettigrew","year":"1985","unstructured":"Pettigrew LC, Jankovic J (1985) Hemidystonia: a report of 22 patients and a review of the literature. J Neurol Neurosurg Psychiatry 48:650\u2013657","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"339_CR126","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jnnp.64.1.13","volume":"64","author":"W Poewe","year":"1998","unstructured":"Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, Kessler KR, Ceballos-Baumann AO, Ohly A, Oertel W, K\u00fcnig G (1998) What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry 64(1):13\u201317","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"339_CR127","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/mds.26760","volume":"31","author":"W Poewe","year":"2016","unstructured":"Poewe W, Burbaud P, Castelnovo G, Jost WH, Ceballos-Baumann AO, Banach M, Potulska-Chromik A, Ferreira JJ, Bihari K, Ehler E, Bares M, Dzyak LA, Belova AN, Pham E, Liu WJ, Picaut P (2016) Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: a randomized-controlled trial. Mov Disord 31(11):1649\u20131657","journal-title":"Mov Disord"},{"key":"339_CR128","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/brain\/118.3.801","volume":"118","author":"A Priori","year":"1995","unstructured":"Priori A, Berardelli A, Mercuri B, Manfredi M (1995) Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 118:801\u2013807","journal-title":"Brain"},{"key":"339_CR129","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/mds.25532","volume":"28","author":"A Quartarone","year":"2013","unstructured":"Quartarone A, Hallett M (2013) Emerging concepts in the physiological basis of dystonia. Mov Disord 28:958\u2013967","journal-title":"Mov Disord"},{"issue":"2","key":"339_CR130","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1523\/JNEUROSCI.3948-05.2006","volume":"26","author":"A Quartarone","year":"2006","unstructured":"Quartarone A, Sant\u2019Angelo A, Battaglia F, Bagnato S, Rizzo V, Morgante F, Rothwell JC, Siebner HR, Girlanda P (2006) Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm. J Neurosci 26(2):716\u2013721","journal-title":"J Neurosci"},{"key":"339_CR131","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.toxicon.2014.07.009","volume":"90","author":"J Ramirez-Castaneda","year":"2014","unstructured":"Ramirez-Castaneda J, Jankovic J (2014) Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon 90:344\u2013348","journal-title":"Toxicon"},{"issue":"13","key":"339_CR132","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/mds.25582","volume":"28","author":"J Ramirez-Castaneda","year":"2013","unstructured":"Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z (2013) Diffusion, spread, and migration of botulinum toxin. Mov Disord 28(13):1775\u20131783","journal-title":"Mov Disord"},{"issue":"4","key":"339_CR133","first-page":"459","volume":"72","author":"D Ranoux","year":"2002","unstructured":"Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M (2002) Respective potencies of botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72(4):459\u2013462","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"339_CR134","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.parkreldis.2017.08.011","volume":"44","author":"M Relja","year":"2017","unstructured":"Relja M, Mileti\u0107 V (2017) When movement disorders hurt: addressing pain in hyperkinetic disorders. Parkinsonism Relat Disord 44:110\u2013113","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"339_CR135","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","volume":"113","author":"P Roggenk\u00e4mper","year":"2006","unstructured":"Roggenk\u00e4mper P, Jost WH, Bihari K, Comes G, Grafe S, Blepharospasm Study Team (2006) Efficacy and safety of a new Botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm (Vienna) 113(3):303\u2013312","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"339_CR136","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","volume":"19","author":"RL Rosales","year":"1996","unstructured":"Rosales RL, Arimura K, Takenaga S, Osame M (1996) Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 19(4):488\u2013496","journal-title":"Muscle Nerve"},{"key":"339_CR137","first-page":"851","volume":"39","author":"JC Rothwell","year":"1983","unstructured":"Rothwell JC, Obeso JA, Day BL, Marsden CD (1983) Pathophysiology of dystonias. Adv Neurol 39:851\u2013863","journal-title":"Adv Neurol"},{"key":"339_CR138","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s12311-014-0569-0","volume":"13","author":"A Sadnicka","year":"2014","unstructured":"Sadnicka A, Patani B, Saifee TA et al (2014) Normal motor adaptation in cervical dystonia: a fundamental cerebellar computation is intact. Cerebellum 13:558\u2013567","journal-title":"Cerebellum"},{"key":"339_CR139","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/ene.12521","volume":"22","author":"A Sadnicka","year":"2015","unstructured":"Sadnicka A, Teo JT, Kojovic M et al (2015) All in the blink of an eye: new insight into cerebellar and brainstem function in DYT1 and DYT6 dystonia. Eur J Neurol 22:762\u2013767","journal-title":"Eur J Neurol"},{"key":"339_CR140","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1038\/s41598-018-21545-0","volume":"8","author":"A Sadnicka","year":"2018","unstructured":"Sadnicka A, Stevenson A, Bhatia KP, Rothwell JC, Edwards MJ, Galea JM (2018) High motor variability in DYT1 dystonia is associated with impaired visuomotor adaptation. Sci Rep 8:3653","journal-title":"Sci Rep"},{"key":"339_CR141","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/mds.23447","volume":"26","author":"A Scontrini","year":"2011","unstructured":"Scontrini A, Conte A, Fabbrini G, Colosimo C, Di Stasio F, Ferrazzano G, Berardelli A (2011) Somatosensory temporal discrimination tested in patients receiving botulinum toxin injection for cervical dystonia. Mov Disord 26:742\u2013746","journal-title":"Mov Disord"},{"issue":"19","key":"339_CR142","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","volume":"86","author":"DM Simpson","year":"2016","unstructured":"Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA (2016) Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the guideline development Subcommittee of the American Academy of Neurology. Neurology 86(19):1818\u20131826","journal-title":"Neurology"},{"key":"339_CR143","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/ana.20270","volume":"56","author":"YH Sohn","year":"2004","unstructured":"Sohn YH, Hallett M (2004) Disturbed surround inhibition in focal hand dystonia. Ann Neurol 56:595\u2013599","journal-title":"Ann Neurol"},{"key":"339_CR144","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/brain\/awr224","volume":"135","author":"M Stamelou","year":"2012","unstructured":"Stamelou M, Edwards MJ, Hallett M, Bhatia KP (2012) The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain 135:1668\u20131681","journal-title":"Brain"},{"issue":"1","key":"339_CR145","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1152\/jn.00383.2003","volume":"92","author":"K Stefan","year":"2004","unstructured":"Stefan K, Wycislo M, Classen J (2004) Modulation of associative human motor cortical plasticity by attention. J Neurophysiol 92(1):66\u201372","journal-title":"J Neurophysiol"},{"issue":"1-2","key":"339_CR146","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jns.2005.03.046","volume":"234","author":"EK Tan","year":"2005","unstructured":"Tan EK, Chan LL, Auchus AP (2005) Hemidystonia precipitated by acute pontine infarct. J Neurol Sci 234(1-2):109\u2013111","journal-title":"J Neurol Sci"},{"issue":"4","key":"339_CR147","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/mds.10383","volume":"18","author":"GW Thickbroom","year":"2003","unstructured":"Thickbroom GW, Byrnes ML, Stell R, Mastaglia FL (2003) Reversible reorganisation of the motor cortical representation of the hand in cervical dystonia. Mov Disord 18(4):395\u2013402","journal-title":"Mov Disord"},{"issue":"10","key":"339_CR148","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1007\/s00415-012-6454-1","volume":"259","author":"M Tinazzi","year":"2012","unstructured":"Tinazzi M, Valeriani M, Squintani G, Corr\u00e0 F, Recchia S, Defazio G, Berardelli A (2012) Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials. J Neurol 259(10):2060\u20132066","journal-title":"J Neurol"},{"key":"339_CR149","doi-asserted-by":"publisher","unstructured":"Tinazzi M, Squintani GM, Bhatia KP, Segatti A, Donato F, Valeriani M, Erro R (2019) Pain in cervical dystonia: evidence of abnormal inhibitory control. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.009","DOI":"10.1016\/j.parkreldis.2019.06.009"},{"issue":"6","key":"339_CR150","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00415-008-0753-6","volume":"255","author":"D Tiple","year":"2008","unstructured":"Tiple D, Strano S, Colosimo C, Fabbrini G, Calcagnini G, Prencipe M, Berardelli A (2008) Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A. J Neurol 255(6):843\u2013847","journal-title":"J Neurol"},{"issue":"6","key":"339_CR151","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/mds.20801","volume":"21","author":"C Trompetto","year":"2006","unstructured":"Trompetto C, Curr\u00e0 A, Buccolieri A, Suppa A, Abbruzzese G, Berardelli A (2006) Botulinum toxin changes intrafusal feedback in dystonia: a study with the tonic vibration reflex. Mov Disord 21(6):777\u2013782","journal-title":"Mov Disord"},{"issue":"7","key":"339_CR152","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/mds.20403","volume":"20","author":"D Truong","year":"2005","unstructured":"Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL (2005) Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 20(7):783\u2013791","journal-title":"Mov Disord"},{"issue":"5","key":"339_CR153","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.parkreldis.2007.11.003","volume":"14","author":"D Truong","year":"2008","unstructured":"Truong D, Comella C, Fernandez HH, Ondo WG, Dysport Benign Essential Blepharospasm Study Group (2008) Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. Parkinsonism Relat Disord 14(5):407\u2013414","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"339_CR154","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.43.1_Part_1.183","volume":"43","author":"JK Tsui","year":"1993","unstructured":"Tsui JK, Bhatt M, Calne S, Calne DB (1993) Botulinum toxin in the treatment of writer\u2019s cramp: a double-blind study. Neurology 43(1):183\u2013185","journal-title":"Neurology"},{"issue":"3","key":"339_CR155","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00002826-199406000-00002","volume":"17","author":"J Valls-Sole","year":"1994","unstructured":"Valls-Sole J, Tolosa ES, Marti MJ, Allam N (1994) Treatment with botulinum toxin injections does not change brainstem interneuronal excitability in patients with cervical dystonia. Clin Neuropharmacol 17(3):229\u2013235","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"339_CR156","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00702-010-0529-x","volume":"118","author":"B Wabbels","year":"2011","unstructured":"Wabbels B, Reichel G, Fulford-Smith A, Wright N, Roggenk\u00e4mper P (2011) Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm. J Neural Transm (Vienna) 118(2):233\u2013239","journal-title":"J Neural Transm (Vienna)"},{"key":"339_CR157","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1002\/mds.21759","volume":"22","author":"R Walsh","year":"2007","unstructured":"Walsh R, Hutchinson M (2007) Molding the sensory cortex: spatial acuity improves after botulinum toxin treatment for cervical dystonia. Mov Disord 22:2443\u20132446","journal-title":"Mov Disord"},{"issue":"Pt10","key":"339_CR158","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/brain\/awl221","volume":"129","author":"D Weise","year":"2006","unstructured":"Weise D, Schramm A, Stefan K, Wolters A, Reiners K, Naumann M, Classen J (2006) The two sides of associative plasticity in writer\u2019s cramp. Brain 129(Pt10):2709\u20132721","journal-title":"Brain"},{"issue":"2","key":"339_CR159","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nbd.2010.11.009","volume":"42","author":"D Weise","year":"2011","unstructured":"Weise D, Schramm A, Beck M, Reiners K, Classen J (2011) Loss of topographic specificity of LTD-like plasticity is a trait marker in focal dystonia. Neurobiol Dis 42(2):171\u2013176","journal-title":"Neurobiol Dis"},{"issue":"1","key":"339_CR160","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/toxins11010021","volume":"11","author":"D Weise","year":"2019","unstructured":"Weise D, Weise CM, Naumann M (2019) Central effects of botulinum neurotoxin-evidence from human studies. Toxins (Basel) 11(1):6","journal-title":"Toxins (Basel)"},{"issue":"2","key":"339_CR161","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF00498587","volume":"292","author":"H Wiegand","year":"1976","unstructured":"Wiegand H, Erdmann G, Wellh\u00f6ner HH (1976) 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 292(2):161\u2013165","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"12","key":"339_CR162","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s004150170028","volume":"248","author":"J Wissel","year":"2001","unstructured":"Wissel J, Kanovsky P, Ruzicka E, Bares M, Hortova H, Streitova H, Jech R, Roth J, Brenneis C, M\u00fcller J, Schnider P, Auff E, Richardson A, Poewe W (2001) Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study. J Neurol 248(12):1073\u20131078","journal-title":"J Neurol"},{"issue":"4","key":"339_CR163","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S1388-2457(01)00478-3","volume":"112","author":"K Wohlfarth","year":"2001","unstructured":"Wohlfarth K, Schubert M, Rothe B, Elek J, Dengler R (2001) Remote F-wave changes after local botulinum toxin application. Clin Neurophysiol 112(4):636\u2013640","journal-title":"Clin Neurophysiol"},{"issue":"10","key":"339_CR164","doi-asserted-by":"publisher","first-page":"e13602","DOI":"10.1371\/journal.pone.0013602","volume":"5","author":"KE Zeuner","year":"2010","unstructured":"Zeuner KE, Knutzen A, Al-Ali A, Hallett M, Deuschl G, Bergmann TO, Siebner HR (2010) Associative stimulation of the supraorbital nerve fails to induce timing-specific plasticity in the human blink reflex. PLoS One 5(10):e13602","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1007\/164_2020_414","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000}}],"container-title":["Handbook of Experimental Pharmacology","Botulinum Toxin Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T19:31:27Z","timestamp":1609875087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030663056","9783030663063"],"references-count":163,"URL":"https:\/\/doi.org\/10.1007\/164_2019_339","relation":{"correction":[{"id-type":"doi","id":"10.1007\/164_2020_414","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"10 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"10 December 2020","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The chapter was inadvertently published without a more specific title according to SEO guidelines. A chapter title needs to be understandable when seen as a stand-alone item, e.g. on PubMed. The chapter title has now been corrected as \u2018The Use of Botulinum Toxin for Treatment of the Dystonias\u2019.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}